Stopped: Low patient accrual.
The goal of this clinical trial is to evaluates the usability, tolerability, and clinical accuracy of the JessieHug device, a wearable medical device for newborns and infants that collects physiological data. The main questions it aims to answer are: * Is the device easily usable for parents of newborns and infants? * Is the device tolerable when worn by infants and are there any safety concerns? * Is the device able to collect clinically accurate physiologic data compared to a FDA-cleared reference device? Participants will: * Place the JessieHug device on their infant two times a week and complete surveys to assess usability, tolerability and safety. * Have one session where the JessieHug device will be worn at the same time as reference device to determine accuracy.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Evaluating usability of the JessieHug measured by a System Usability Survey
Timeframe: Every other week for through study completion (8 weeks)
Evaluating tolerability of the JessieHug measured by the Face, Legs, Activity, Cry, and Consolability Scale (FLACC) survey, which is an observer reported outcomes (ObsRO) survey.
Timeframe: Every week for through study completion (8 weeks)
Evaluating safety of the JessieHug assessed through a survey assessing adverse events and pain.
Timeframe: Every week for through study completion (8 weeks)
Percent caregiver completing all steps without errors
Timeframe: At baseline